digital health companies glp-1 management Dr. Craig Primack talks Hims & Hers launching its own offering as demand rises The future of GLP-1 drugs

Compounded versions from telehealth platforms like Elevate Health are substantially less expensive because they are not brand-name FDA-approved products and are not marketed by pharmaceutical manufacturers with associated research, development, and marketing costs

Many more are in active clinical trials or used as research compounds

If coverage is denied or excluded, explore savings card, LillyDirect pricing, and your appeal options

10.1016/j.chom.2023.01.009 53

Need help with your weight loss journey

A 2020 review for the American Heart Association highlighted that even modest improvements in insulin sensitivity during midlife can significantly reduce future cardiovascular and cognitive risk